BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 8271954)

  • 1. Cellular receptor for urokinase-type plasminogen activator: protein structure.
    Behrendt N; Ploug M; Rønne E; Høyer-Hansen G; Danø K
    Methods Enzymol; 1993; 223():207-22. PubMed ID: 8271954
    [No Abstract]   [Full Text] [Related]  

  • 2. Urokinase-type plasminogen-activator receptor associates to a cell surface molecule in monocytic cells.
    Ragno P; Montuori N; Rossi G
    Biochem Biophys Res Commun; 1996 Jul; 224(1):252-7. PubMed ID: 8694822
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A hybrid protein of urokinase growth-factor domain and plasminogen-activator inhibitor type 2 inhibits urokinase activity and binds to the urokinase receptor.
    Ballance DJ; Marshall JM; Cottingham IR; Steven J; Berry SJ; Cederholm-Williams SA; Goodey AR; Courtney M
    Eur J Biochem; 1992 Jul; 207(1):177-83. PubMed ID: 1321039
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel, specific pro-urokinase complex on monocyte-like cells, detected by transglutaminase-catalyzed cross-linking.
    Behrendt N; Rønne E; Danø K
    FEBS Lett; 1993 Dec; 336(3):394-6. PubMed ID: 7904248
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification and characterization of the murine cell surface receptor for the urokinase-type plasminogen activator.
    Solberg H; Løber D; Eriksen J; Ploug M; Rønne E; Behrendt N; Danø K; Høyer-Hansen G
    Eur J Biochem; 1992 Apr; 205(2):451-8. PubMed ID: 1374026
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The human receptor for urokinase plasminogen activator. NH2-terminal amino acid sequence and glycosylation variants.
    Behrendt N; Rønne E; Ploug M; Petri T; Løber D; Nielsen LS; Schleuning WD; Blasi F; Appella E; Danø K
    J Biol Chem; 1990 Apr; 265(11):6453-60. PubMed ID: 2156852
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A 55,000-60,000 Mr receptor protein for urokinase-type plasminogen activator. Identification in human tumor cell lines and partial purification.
    Nielsen LS; Kellerman GM; Behrendt N; Picone R; Danø K; Blasi F
    J Biol Chem; 1988 Feb; 263(5):2358-63. PubMed ID: 2828365
    [TBL] [Abstract][Full Text] [Related]  

  • 8. N-linked glycosylation of the ligand-binding domain of the human urokinase receptor contributes to the affinity for its ligand.
    Møller LB; Pöllänen J; Rønne E; Pedersen N; Blasi F
    J Biol Chem; 1993 May; 268(15):11152-9. PubMed ID: 8388383
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cellular receptor for urokinase-type plasminogen activator: function in cell-surface proteolysis.
    Ellis V; Behrendt N; Danø K
    Methods Enzymol; 1993; 223():223-33. PubMed ID: 8271955
    [No Abstract]   [Full Text] [Related]  

  • 10. Soluble urokinase receptor from fibrosarcoma HT-1080 cells.
    Lau HK; Kim M
    Blood Coagul Fibrinolysis; 1994 Aug; 5(4):473-8. PubMed ID: 7841301
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cellular receptor for urokinase plasminogen activator. Carboxyl-terminal processing and membrane anchoring by glycosyl-phosphatidylinositol.
    Ploug M; Rønne E; Behrendt N; Jensen AL; Blasi F; Danø K
    J Biol Chem; 1991 Jan; 266(3):1926-33. PubMed ID: 1846368
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Saturation of tumour cell surface receptors for urokinase-type plasminogen activator by amino-terminal fragment and subsequent effect on reconstituted basement membranes invasion.
    Kobayashi H; Ohi H; Shinohara H; Sugimura M; Fujii T; Terao T; Schmitt M; Goretzki L; Chucholowski N; Jänicke F
    Br J Cancer; 1993 Mar; 67(3):537-44. PubMed ID: 8382511
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structure of human urokinase plasminogen activator in complex with its receptor.
    Huai Q; Mazar AP; Kuo A; Parry GC; Shaw DE; Callahan J; Li Y; Yuan C; Bian C; Chen L; Furie B; Furie BC; Cines DB; Huang M
    Science; 2006 Feb; 311(5761):656-9. PubMed ID: 16456079
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The growth factor module of urokinase is the binding sequence for its receptor.
    Appella E; Blasi F
    Ann N Y Acad Sci; 1987; 511():192-5. PubMed ID: 2830824
    [No Abstract]   [Full Text] [Related]  

  • 15. Processing of complex between urokinase and its type-2 inhibitor on the cell surface. A possible regulatory mechanism of urokinase activity.
    Ragno P; Montuori N; Vassalli JD; Rossi G
    FEBS Lett; 1993 Jun; 323(3):279-84. PubMed ID: 8388810
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of urokinase receptors in monocytelike U937 cells by phorbol ester phorbol myristate acetate.
    Picone R; Kajtaniak EL; Nielsen LS; Behrendt N; Mastronicola MR; Cubellis MV; Stoppelli MP; Pedersen S; Danø K; Blasi F
    J Cell Biol; 1989 Feb; 108(2):693-702. PubMed ID: 2537321
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interaction of urokinase-type plasminogenactivator (u-PA) with its cellular receptor (u-PAR) induces phosphorylation on tyrosine of a 38 kDa protein.
    Dumler I; Petri T; Schleuning WD
    FEBS Lett; 1993 May; 322(1):37-40. PubMed ID: 8387028
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Urokinase binding and receptor identification in cultured endothelial cells.
    Haddock RC; Spell ML; Baker CD; Grammer JR; Parks JM; Speidel M; Booyse FM
    J Biol Chem; 1991 Nov; 266(32):21466-73. PubMed ID: 1657968
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Urokinase-type plasminogen activator/type-2 plasminogen-activator inhibitor complexes are not internalized upon binding to the urokinase-type-plasminogen-activator receptor in THP-1 cells. Interaction of urokinase-type plasminogen activator/type-2 plasminogen-activator inhibitor complexes with the cell surface.
    Ragno P; Montuori N; Rossi G
    Eur J Biochem; 1995 Oct; 233(2):514-9. PubMed ID: 7588796
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The mechanism of activation of rabbit plasminogen by urokinase. Lack of a preactivation peptide.
    Sodetz JM; Brockway WJ; Mann KG; Castellino FJ
    Biochem Biophys Res Commun; 1974 Sep; 60(2):729-36. PubMed ID: 4278813
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.